ES2148578T3 - Soporte de medicamento para un inhalador de polvo seco y procedimiento de fabricacion del mismo. - Google Patents

Soporte de medicamento para un inhalador de polvo seco y procedimiento de fabricacion del mismo.

Info

Publication number
ES2148578T3
ES2148578T3 ES95937656T ES95937656T ES2148578T3 ES 2148578 T3 ES2148578 T3 ES 2148578T3 ES 95937656 T ES95937656 T ES 95937656T ES 95937656 T ES95937656 T ES 95937656T ES 2148578 T3 ES2148578 T3 ES 2148578T3
Authority
ES
Spain
Prior art keywords
dry powder
powder inhaler
manufacturing procedure
screening
medication support
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95937656T
Other languages
English (en)
Inventor
Oort Michiel M Van
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
Glaxo Wellcome Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/328,578 external-priority patent/US5647347A/en
Priority claimed from US08/328,577 external-priority patent/US5503869A/en
Application filed by Glaxo Wellcome Inc filed Critical Glaxo Wellcome Inc
Application granted granted Critical
Publication of ES2148578T3 publication Critical patent/ES2148578T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/0028Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • A61M15/0045Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using multiple prepacked dosages on a same carrier, e.g. blisters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/0028Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • A61M15/0045Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using multiple prepacked dosages on a same carrier, e.g. blisters
    • A61M15/0046Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using multiple prepacked dosages on a same carrier, e.g. blisters characterized by the type of carrier
    • A61M15/0048Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using multiple prepacked dosages on a same carrier, e.g. blisters characterized by the type of carrier the dosages being arranged in a plane, e.g. on diskettes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/0028Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • A61M15/0045Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using multiple prepacked dosages on a same carrier, e.g. blisters
    • A61M15/0046Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using multiple prepacked dosages on a same carrier, e.g. blisters characterized by the type of carrier
    • A61M15/005Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using multiple prepacked dosages on a same carrier, e.g. blisters characterized by the type of carrier the dosages being arranged on a cylindrical surface
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/0028Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • A61M15/0045Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using multiple prepacked dosages on a same carrier, e.g. blisters
    • A61M15/0046Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using multiple prepacked dosages on a same carrier, e.g. blisters characterized by the type of carrier
    • A61M15/0051Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using multiple prepacked dosages on a same carrier, e.g. blisters characterized by the type of carrier the dosages being arranged on a tape, e.g. strips
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/0028Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • A61M15/0045Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using multiple prepacked dosages on a same carrier, e.g. blisters
    • A61M15/0053Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using multiple prepacked dosages on a same carrier, e.g. blisters characterized by the type or way of disposal
    • A61M15/0055Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using multiple prepacked dosages on a same carrier, e.g. blisters characterized by the type or way of disposal the used dosages being coiled
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00Special media to be introduced, removed or treated
    • A61M2202/06Solids
    • A61M2202/064Powder

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Application Of Or Painting With Fluid Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

LA PRESENTE INVENCION ESTA RELACIONADA CON UN VEHICULO DE MEDICAMENTO PARA UTILIZAR EN UN DISPOSITIVO INHALADOR DE POLVO SECO, Y UN PROCESO PARA FORMAR EL MISMO EN EL QUE EL VEHICULO DE MEDICAMENTO TIENE AL MENOS UNA PORCION DE TAMIZADO. LA PORCION DE TAMIZADO DEFINE UNA PLURALIDAD DE INTERSTICIOS EN SU INTERIOR Y TRANSPORTA UN MEDICAMENTO EN POLVO, QUE PUEDE SER APLICADO EN UNA SUSPENSION PARA A CONTINUACION EVAPORAR EL AGENTE SUSPENSOR, Y EL CUAL ES CARGADO EN LA SUPERFICIE DE LA PORCION DE TAMIZADO, DE FORMA QUE LOS INTERSTICIOS DE LA PROPORCION DE TAMIZADO ESTAN AL MENOS PARCIALMENTE ABIERTOS Y LIBRES DE MEDICAMENTO EN POLVO SECO.
ES95937656T 1994-10-21 1995-10-19 Soporte de medicamento para un inhalador de polvo seco y procedimiento de fabricacion del mismo. Expired - Lifetime ES2148578T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/328,578 US5647347A (en) 1994-10-21 1994-10-21 Medicament carrier for dry powder inhalator
US08/328,577 US5503869A (en) 1994-10-21 1994-10-21 Process for forming medicament carrier for dry powder inhalator

Publications (1)

Publication Number Publication Date
ES2148578T3 true ES2148578T3 (es) 2000-10-16

Family

ID=26986433

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95937656T Expired - Lifetime ES2148578T3 (es) 1994-10-21 1995-10-19 Soporte de medicamento para un inhalador de polvo seco y procedimiento de fabricacion del mismo.

Country Status (17)

Country Link
EP (2) EP0843566B1 (es)
JP (1) JPH10507669A (es)
KR (1) KR970706861A (es)
AT (2) ATE232120T1 (es)
AU (1) AU703618B2 (es)
BR (1) BR9509392A (es)
CA (1) CA2202919A1 (es)
CZ (1) CZ287811B6 (es)
DE (2) DE69529581T2 (es)
ES (1) ES2148578T3 (es)
FI (1) FI971676A7 (es)
HU (1) HU219094B (es)
MX (1) MX9702799A (es)
NO (1) NO971817L (es)
NZ (1) NZ296010A (es)
PL (1) PL178716B1 (es)
WO (1) WO1996012515A2 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19533023B4 (de) 1994-10-14 2007-05-16 Basf Ag Neue Carbonsäurederivate, ihre Herstellung und Verwendung
GB9610821D0 (en) * 1996-05-23 1996-07-31 Glaxo Wellcome Inc Metering apparatus
GB9616047D0 (en) 1996-07-31 1996-09-11 Glaxo Group Ltd Medicament carrier with agglomerated large medicament particles and related method of manufacture thereof
EP1416990A1 (en) * 2001-08-09 2004-05-12 Glaxo Group Limited Inhalation device with a pharmaceutical composition
US8037880B2 (en) 2006-04-07 2011-10-18 The University Of Western Ontario Dry powder inhaler
IL191190A0 (en) * 2008-05-01 2009-08-03 Dan Adler Dry powder inhaler

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1313805C (en) * 1988-10-19 1993-02-23 Hermann Schwartz Article for simulation of smoking
GB8909891D0 (en) * 1989-04-28 1989-06-14 Riker Laboratories Inc Device
WO1992000115A1 (de) * 1990-06-28 1992-01-09 Boehringer Ingelheim Kg Vorrichtung und verfahren zur pulverdosierung
US5441060A (en) * 1993-02-08 1995-08-15 Duke University Dry powder delivery system
FI954098A7 (fi) * 1993-03-03 1995-09-01 Tenax Corp Kuivajauheen inhalaattorin lääkeaineen kantolaite

Also Published As

Publication number Publication date
NO971817D0 (no) 1997-04-18
EP0843566B1 (en) 2000-05-10
WO1996012515A2 (en) 1996-05-02
CZ120897A3 (en) 1997-10-15
ATE192660T1 (de) 2000-05-15
AU703618B2 (en) 1999-03-25
EP0987041A1 (en) 2000-03-22
MX9702799A (es) 1997-06-28
DE69529581D1 (de) 2003-03-13
PL319814A1 (en) 1997-09-01
FI971676A0 (fi) 1997-04-18
FI971676L (fi) 1997-06-16
EP0843566A2 (en) 1998-05-27
BR9509392A (pt) 1997-09-16
KR970706861A (ko) 1997-12-01
ATE232120T1 (de) 2003-02-15
NO971817L (no) 1997-06-18
DE69529581T2 (de) 2003-09-04
CA2202919A1 (en) 1996-05-02
DE69516909D1 (de) 2000-06-15
PL178716B1 (pl) 2000-06-30
AU3969895A (en) 1996-05-15
NZ296010A (en) 1998-10-28
HU219094B (hu) 2001-02-28
WO1996012515A3 (en) 1996-08-01
HUT77657A (hu) 1998-07-28
EP0987041B1 (en) 2003-02-05
DE69516909T2 (de) 2000-11-02
JPH10507669A (ja) 1998-07-28
FI971676A7 (fi) 1997-06-16
CZ287811B6 (en) 2001-02-14

Similar Documents

Publication Publication Date Title
ES2148836T3 (es) Elemento en forma de hoja.
ES2152990T3 (es) Principios activos y microparticulas que contienen gases.
MX9702357A (es) Microparticulas secadas por aspersion como vehiculos terapeuticos.
ES2130217T3 (es) Uso de tiloxapol como dispersante y estabilizante de nanoparticulas.
AR241103A1 (es) "dispositivo de rebajamiento del ala de una butaca anatomica envolvente para el vehiculo automotor o analogo, y butaca que comprende dicho dispositivo".
ES2117435T3 (es) Catalizador soportado de polimerizacion de olefinas.
ES2052947T3 (es) Nueva forma unitaria, solida y porosa que comprende microparticulas y/o nanoparticulas asi como su preparacion.
CO5600993A2 (es) Red no tejida que incluye una region superabsorbente y articulos que incluyen la misma
ES2038823T3 (es) Material en lamina usado para formar partes de sujetadores.
ES2103946T3 (es) Excipiente farmaceutico.
ES2179880T3 (es) Tratamiento del cancer utilizando un mutante del hsv.
ES2125065T3 (es) Articulo fosforescente.
ES2130206T3 (es) Articulo absorbente.
DE69811278D1 (de) Gegen magensaft geschützte omeprazol-mikrogranülen, herstellungsverfahren und pharmazeutische zubereitungen
AR028764A1 (es) Boquilla para la aplicacion de un producto cosmetico, su procedimiento de fabricacion y dispositivo de acondicionamiento y de aplicacion que utiliza dicha boquilla
UA27043C2 (uk) Мікросферичhі частиhки для пареhтеральhої іh'єкції фармацевтичhо активhої речовиhи при її коhтрольоваhому виділеhhі в оргаhізмі після іh'єкції, спосіб їх одержаhhя та суспеhзія hа осhові даhих мікросфер
SV1995000010A (es) Prenda absorbente con un manejo mejorado de las emanaciones
ES2235311T8 (es) Formulación de budesónida/formoterol para inhalación que tiene una densidad aparente de vertido de 0,30 a 0,36 g/ml, un proceso para preparar la formulación y el uso de la misma.
SE8803084D0 (sv) Dosage form compromising fast agent delivery followed by slow agent delivery
MX9200074A (es) Procedimiento y dispositivo para la produccion de particulas abrasivas filamentosas.
ES2148198T3 (es) Procedimiento de trituracion de sustancias farmaceuticas.
ES2115684T3 (es) Articulo abrasivo con miembros de material compuesto abrasivo situados en rebajos.
BR9808783A (pt) Compósito absorvente, artigo absorvente, e, processo de preparação de um compósito absorvente
ES8705236A1 (es) Un procedimiento para fabricar una unidad refrescante de aire.
ES2148578T3 (es) Soporte de medicamento para un inhalador de polvo seco y procedimiento de fabricacion del mismo.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 843566

Country of ref document: ES